Tarsus Collection (6 videos)

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis: Phase 2 Io and Europa Trials

Channels: Cornea, General, Optometry

Roberto Gonzalez-Salinas, MD, PhD, provides an overview of the results from the latest Phase 2 clinical trials evaluating the safety and efficacy of TP-03 (Tarsus Pharmaceuticals), a novel drug for the treatment of Demodex blepharitis. The Io Study was a Phase 2a pilot study, and the Europa Study was a Phase 2b randomized controlled study.

Demodex blepharitis • Tarsus • TP-03

Visit Us Online